#Class Action #Canada #Montreal #Settlement #Rexulti

Extended Deadline for Claims in the National Rexulti Class Action Settlement

The Superior Court of Québec has recently approved a significant settlement of CAD $4.75 million concerning claims related to the prescription medication REXULTI®. This settlement aims to address the experiences of individuals across Canada who were prescribed REXULTI® between February 16, 2017, and August 23, 2025, and subsequently faced serious side effects including compulsive behaviors and impulse control disorders such as compulsive gambling, hypersexuality, compulsive shopping/spending, and binge-eating.

As crucial news for those impacted, the deadline to submit claims has been officially extended from the original date of July 27, 2026, to August 27, 2026. Stakeholders are encouraged to act promptly since failure to submit a Claim Form by the new deadline could result in losing the opportunity to receive any part of the settlement.

Claim Forms can be accessed directly from the Settlement Website at Rexulticlassactionsettlement.com. Completing this form is the first step to potentially receiving compensation under the approved settlement. It is vital to ensure that all necessary documentation is provided to avoid any issues with claims being processed.

Once the claims are submitted, they will undergo a thorough review by MNP Ltd., the Claims Administrator appointed by the Court. The amounts distributed will be in accordance with the Distribution Protocol established by the Court, which outlines the process and criteria for compensation. Claimants should be aware that the actual compensation received may differ from the estimates provided, as it largely depends on how many eligible claimants come forward.

Rochon Genova serves as the Class Counsel in this class action lawsuit, advocating for those affected. If you have questions regarding the settlement, your rights, or the protocol for filing a claim, assistance is readily available. You can reach out to Rochon Genova directly either via email at [email protected] or by calling 1-866-881-2292. Alternatively, inquiries can be directed to the Court Appointed Claims Administrator via email at [email protected] or by calling 1-855-653-0027.

It is crucial for all individuals who fit the criteria to be proactive in submitting their claims before the August 27 deadline. This is an essential step for eligible recipients to secure compensation for the adverse impacts they may have experienced while taking REXULTI®. Being informed and acting swiftly will ensure that those affected by this issue receive the support they need and deserve.

The announcements made about this settlement underline the legal framework in place to protect consumers and ensure accountability from pharmaceutical companies regarding the safety and side effects of their medications. As more cases and settlements unfold, it highlights the importance of vigilance and active participation in protecting one’s legal rights when it comes to pharmaceutical prescriptions.